Cancer therapeutics currently have the lowest clinical trial success rate of all major
diseases. Partly as a result of the paucity of successful anti-cancer drugs, cancer will soon …

Although the metabolic syndrome is a commonplace topic, its potential threats to public
health is a problem that cannot be neglected. As the living conditions improved significantly …

Genome-wide association studies (GWAS) have emerged as an important tool for
discovering regions of the genome that harbor genetic variants that confer risk for different …

Elusion or inspired scientific reality? Personalized medicine could revolutionize cancer
management, if robust prognostic and predictive tools can be developed. However, there is …

Overwhelming epidemiological evidence demonstrate that cardiovascular disease and
cancer represent major health burdens in the United States, and they are the leading causes …

Abstract Background Metabolic syndrome (MetS) has been related to the pathogenesis of
variety categories of cancers. This meta-analysis aimed to determine the association …

All multicellular organisms are made up of millions of cells. Under physiological conditions,
the cells usually behave in a specific biological manner to sustain a normal healthy life …

Despite improvements in the understanding of cancer causation, much remains unknown
regarding the mechanisms by which genomic and non-genomic factors initiate …

Background There is little knowledge on the dose-response association between
cardiovascular health (CVH) and risk of all-cause, cardiovascular disease (CVD) and cancer …

Clear and unambiguous associations have been established between therapeutic
exposures and specific complications. However, considerable interindividual variability is …